NCT02690181
- Conditions
- Bacterial Infection Due to Streptococcus, Group B, Streptococcus Agalactiae
- Locations
-
- GSK Investigational Site Ghent, Belgium
Clinical trial condition
Streptococcus Agalactiae
Explore clinical trials studying Streptococcus Agalactiae. Study availability and eligibility vary by location and protocol.
5 public trials
0 recruiting studies
Streptococcus Agalactiae trial results
NCT05005169
- Conditions
- Disease Attributes, Disease Progression, Pathologic Complete Response, +3 more
- Locations
-
- Multon Nantes, Saint Herblain, France
- Gillard Angers, France
- Sentilhes Bordeaux, France
- Houllier Le Kremlin-Bicêtre, France
Completed
Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
NCT02046148
- Conditions
- GBS Disease, Streptococcus Agalactiae
- Locations
-
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Baltimore, Maryland, United States
- GSK Investigational Site Durham, North Carolina, United States
- GSK Investigational Site Pittsburgh, Pennsylvania, United States
- Conditions
- Streptococcus Agalactiae
- Locations
-
- GSK Investigational Site Johannesburg, South Africa
Completed
Real-Time PCR for the Detection of Vaginal Group B Streptococcus Carriage: a Medico-Economic Study
NCT00920530
- Conditions
- Neonatal Infections, Streptococcus Agalactiae
- Locations
-
- CHU de Saint-Etienne Saint-Etienne, France